CYTK

50.7801.32%
AM

Andrew M. Callos

Executive VP & Chief Commercial Officer

Mr. Andrew M. Callos serves as an Executive Vice President and Chief Commercial Officer at Cytokinetics, Incorporated since joining in March 2021. Mr. Andrew has a deep biopharma background which includes many years at Pfizer and Wyeth Pharmaceuticals, including roles of increasing responsibility overseeing US and International pharmaceutical franchises. From October 2009 to November 2020, Mr. Callos held various positions at Pfizer, Incorporated Most recently, from October 2018 to his departure from Pfizer, Mr. Callos served as Regional President & General Manager North America of Pfizer Upjohn Business Unit. In his over eleven year career at Pfizer, Mr. Callos also served as Vice President U.S. Cardiology & Metabolic Marketing from January 2015 to October 2018, Vice President and Head of Inflammation Marketing Europe from May2013 to January 2015, and Vice President Global Commercial Development Rare Disease and Specialty Care from October 2009 to April 2013. From August 1999 to October 2009, Mr. Andrew spent many years at Wyeth Pharmaceuticals in various roles within Business Planning & Analysis, ultimately serving as AVP Marketing across several products. Mr. Callos started initial years of his career as a Consulting Manager at Accenture. Mr. Andrew received B.S. in Commerce and Engineering from Drexel University.

Positions